articleTop 1% cited
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial
Gastroenterology · 2006 · Vol. 130(2) · pp. 323–333
Stephen B. Hanauer✉(University of Chicago Medical Center)William J. Sandborn(WinnMed)Paul Rutgeerts(Universitair Ziekenhuis Leuven)Richard N. Fedorak(University of Alberta)Milan Lukáš(Charles University)Donald MacIntosh(Dalhousie University)Remo Panaccione(University of Calgary)Douglas C. Wolf(Atlanta Gastroenterology Associates)Paul Pollack(Reckitt Benckiser (United States))
Inflammatory Bowel DiseaseMicroscopic ColitisAutoimmune and Inflammatory Disorders ResearchAdalimumabMonoclonal antibodyMedicineCrohn's diseaseTumor necrosis factor alphaMonoclonalNecrosisDiseaseTumor necrosis factorsImmunology
MeSH terms
AdalimumabAdultAgedAntibodies, MonoclonalCrohn DiseaseFemaleHumansMaleMiddle AgedPlacebosSafetyTumor Necrosis Factor-alphaTreatment OutcomePatient SelectionAntibodies, Monoclonal, Humanized
Citations
1,710
FWCI
65.16
field-weighted impact
References
33
Percentile
100%
vs. same field & year
Citations per year
Cited by
Management of psoriasis as a systemic disease: what is the evidence?
British Journal of Dermatology · 2019 · 498 citations
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Gut · 2012 · 1,472 citations
Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
Gut · 2007 · 1,030 citations
Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula
Diseases of the Colon & Rectum · 2016 · 386 citations
ACG Clinical Guideline: Management of Crohn's Disease in Adults
The American Journal of Gastroenterology · 2018 · 1,376 citations
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
The American Journal of Gastroenterology · 2015 · 1,802 citations
Guidelines for the management of inflammatory bowel disease in adults
Gut · 2011 · 1,432 citations
Crohn Disease: Epidemiology, Diagnosis, and Management
Mayo Clinic Proceedings · 2017 · 526 citations
References
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
Arthritis & Rheumatism · 2003 · 1,756 citations
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial
Arthritis & Rheumatism · 2004 · 1,168 citations
Development of a Crohn's Disease Activity Index
Gastroenterology · 1976 · 3,130 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.